健脾利湿益气养阴方治疗PCOS伴IR的临床观察
本文选题:健脾理湿益气养阴方 切入点:多囊卵巢综合征 出处:《黑龙江省中医药科学院》2016年硕士论文 论文类型:学位论文
【摘要】:目的:旨在观察健脾利湿益气养阴方对多囊卵巢伴有胰岛素抵抗的病患内分泌、代谢、排卵情况等影响,探讨其治疗多囊卵巢综合征伴有胰岛素抵抗疗效机理。方法:临床研究采用对照和随机的研究方法,将符合多囊卵巢综合征伴有胰岛素抵抗的病患,按1:1对照的原则,随机分为治疗组与对照组。在基础治疗之上,治疗组给予中药配方颗粒每日1剂,分早晚两次饭后服用;对照组给予二甲双胍500mg,每天2次,饭后服用。以1个月经周期为1个疗程,连续观察3个疗程。两组在治疗前后分别评价多囊卵巢伴有胰岛素抵抗的临床症状、其体征变化及实验室指标。全部数据都以SPSS16.0统计软件进行统计学的分析。结果:1.临床疗效方面:治疗组总有效率为93.33%。对照组总有效率为73.33%。治疗组优于对照组(P0.05)。2.中医症候方面:治疗组症候积分疗后较疗前明显下降(P0.01);对照组症候积分较治疗前无明显改变(P0.05),治疗组优于对照组(P0.01),疗后三个月治疗组优于对照组(P0.01)。3.临床症状及体征方面:(1)治疗后两组患者月经情况均有改善(P0.01),治疗组优于对照组(P0.05),疗后三个月月经改善稳定情况治疗组优于对照组(P0.05)。(2)治疗后两组患者BMI较治疗前均有所下降(P0.01),治疗组优于对照组(P0.05),疗后三个月治疗组优于对照组(P0.01)。(3)疗后、疗后三个月治疗组患者多毛情况、痤疮较治疗前有所改善(P0.01),对照组改善情况不明显(P0.05),治疗组优于对照组(P0.01)。(4)治疗后两组患者黑棘皮情况均有改善(P0.01),两组改善程度无差异(P0.05),疗后三个月治疗组优于对照组(P0.01)。4.性激素水平方面:(1)治疗后两组患者的T值均较治疗前有所下降(P0.05),治疗组雄激素下降程度优于对照组(P0.05)。(2)治疗后两组患者LH值、LH/FSH值较治疗前均有所下降(P0.01),且治疗组下降程度优于对照组(P0.05)。(3)治疗前后两组患者FSH值、E2值无明显差异(P0.05)。5.胰岛素相关指标方面:治疗后两组患者FINS值、ISI值较治疗前均有改善(P0.05),治疗组改善程度与对照组无差异(P0.05)。治疗前后两组患者FPG无明显差异。6.彩超影像学方面:治疗后两组患者窦卵泡数目较治疗前有所下降(P0.05),且治疗组窦卵泡数减少量优于对照组(P0.05)。7.排卵情况(基础体温测定)方面:疗后、疗后三个月两组患者基础体温双相率分别为40%、16.67%、33.33%、10%,治疗组效果优于对照组(P0.05)。8.安全性指标方面:治疗前后两组患者血、尿、便常规及肝、肾功能均在正常范围之内。两组均未见明显不良反应。结论:1.健脾利湿益气养阴方结合基础治疗可改善胰岛素抵抗(主要为降低FINS)。治疗效果与二甲双胍结合基础治疗相当。2.健脾利湿益气养阴方结合基础治疗可显著改善多囊卵巢综合征症候群,且疗后三个月复发率低。治疗效果优于二甲双胍结合基础治疗。
[Abstract]:Objective: to observe the effects of invigorating spleen, dampness and supplementing qi and nourishing yin on endocrine, metabolism and ovulation in patients with polycystic ovary accompanied by insulin resistance. Methods: control and randomized methods were used to treat patients with polycystic ovary syndrome with insulin resistance according to the principle of 1: 1 control. The treatment group was divided into treatment group and control group at random. On the basis of basic treatment, the treatment group was given 1 dose of traditional Chinese medicine prescription granule daily, taken after two meals in the morning and evening, while the control group was given metformin 500 mg twice a day, One menstrual cycle was used as a course of treatment, and three consecutive courses of treatment were observed. The clinical symptoms of polycystic ovary with insulin resistance were evaluated before and after treatment. All the data were analyzed statistically by SPSS16.0 software. Results: 1. Clinical efficacy: the total effective rate of the treatment group was 93.33. The total effective rate of the control group was 73.33. The treatment group was superior to the control group (P0.05. 2). The symptom score of the treatment group was significantly lower than that of the control group after treatment, while that of the control group had no significant change compared with that before treatment, the treatment group was superior to the control group, and the treatment group was superior to the control group three months after treatment. The clinical symptoms and signs of the treatment group were better than that of the control group. (1) after treatment, the menstrual status of the two groups was improved, the treatment group was superior to the control group (P 0.05), the treatment group was superior to the control group in improving menstrual stability three months after treatment, and the control group was superior to the control group (P 0.05). After treatment, the BMI of the two groups was lower than that of the control group (P 0.01), and the treatment group was better than that of the control group (P 0.01). The treatment group was superior to the control group (P 0.05), and the treatment group was superior to the control group (P 0.01) three months after treatment. Three months after treatment, the patients in the treatment group suffered from hirsutism. The acnes in the treatment group was better than that in the control group (P 0.01). There was no difference in the degree of improvement between the two groups. The treatment group was superior to the control group in three months after treatment, and the treatment group was superior to the control group. After the treatment, the T value of the two groups was lower than that before treatment. The decrease of androgen in the treatment group was better than that in the control group (P 0.05. 0. 2) after treatment, the LH value and the LH / FSH value of the two groups were lower than those before treatment, and the treatment group had a decrease in the value of LHP / FSH, and the treatment group had a lower value of LH / FSH than that of the control group (P < 0. 05, P < 0. 05, P < 0. 05). Before and after treatment, there was no significant difference in FSH value and E2 value between the two groups. Insulin related indexes: after treatment, the FINS value of the two groups was improved compared with that of the control group (P 0.05), and the improvement degree of the treatment group was higher than that of the control group. There was no significant difference in FPG between the two groups before and after treatment. 6. Color Doppler Imaging: the number of antral follicles in the two groups was lower than that before treatment, and the number of antral follicles in the treatment group was lower than that in the control group. Basic body temperature measurement): after treatment, Three months after treatment, the biphasic rates of basic body temperature in the two groups were 40 ~ 16.67 ~ 33.33 and 10, respectively. The effect of the treatment group was better than that of the control group (P 0.05) .8. the safety indexes were as follows: before and after treatment, the patients in the two groups had blood, urine, stool routine and liver. The renal function was within normal range. There were no obvious adverse reactions in the two groups. Conclusion 1. The combination of tonifying spleen, dampness and supplementing qi and nourishing yin can improve insulin resistance (mainly reducing FINSN). The therapeutic effect is based on metformin. 2. The combination of invigorating spleen, dampness and supplementing qi and nourishing yin can significantly improve the syndrome of polycystic ovary syndrome. The recurrence rate was low 3 months after treatment and the therapeutic effect was better than metformin combined with basic treatment.
【学位授予单位】:黑龙江省中医药科学院
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R271.9
【相似文献】
相关期刊论文 前10条
1 郭文;罗素明;魏可新;李景云;;用于校准~(192)Ir医用源的阱型电离室[J];原子能科学技术;2007年01期
2 陈明,刘兆平,王日胜,霍勇;~(192)Ir血管内照射防止兔球囊血管成形术后再狭窄[J];中国介入心脏病学杂志;2000年03期
3 陈明,霍勇,刘兆平,王日胜,朱国英;~(192)Ir血管内照射防止兔球囊血管成形术后再狭窄[J];Chinese Medical Journal;2001年01期
4 聂波;张贵君;孙素琴;周群;丁万隆;;不同金莲花药材的IR鉴别研究[J];中药材;2006年04期
5 白震民;原一;唐强;陈世龙;;针刺对IR模型大鼠胰岛素敏感性的影响[J];针灸临床杂志;2007年08期
6 张旭光,山常起,马旺扣,吴翼伟,王栋梁;~(192)Ir颗粒源的制造和辐射剂量检测[J];中华核医学杂志;2004年02期
7 田宜清,王晓霞;一例~(192)Ir源放射事故调查处理报告[J];职业与健康;2001年07期
8 王进;杨春勇;余宁乐;许翠珍;杜翔;张乙眉;;江苏省后装近距离治疗机~(192)Ir放射源有效活度检测与分析[J];辐射防护;2009年04期
9 张红志,殷蔚伯,冯宁远,,余子豪;近距离治疗中~(192)Ir放射源的校准[J];中华放射肿瘤学杂志;1997年01期
10 钦志泉,张苏展,卢丽琴,刘子江,贾勇士,吴树强;~(192)Ir内放疗增加肺癌动脉化疗和外照射疗效的临床研究[J];肿瘤防治杂志;2003年01期
相关会议论文 前10条
1 刘羽;刘翠;梁良;黄澜;朱华;许艳峰;秦川;;小鼠脑部SIRT1与IRα受体的共定位及分布[A];第十届中国实验动物科学年会论文集[C];2012年
2 陈贻竹;Murchie EH;Peng SB;Horton P;;水稻IR系列品种的光合作用和叶绿素荧光的特性[A];全国植物光合作用、光生物学及其相关的分子生物学学术研讨会论文摘要汇编[C];2001年
3 廖勇;马弘舸;杨周炳;李科;谢平;孟凡宝;;4.5m抛物面冲击脉冲天线(IR)实验[A];中国工程物理研究院科技年报(2003)[C];2003年
4 ;降低彩电MT822机芯IR板产品不良率[A];QCC—开发潜能 和谐提升——2010年度电子信息行业优秀质量管理小组成果、质量信得过班组经验专集[C];2010年
5 宁建华;;电铸成型的Ir/Re火箭发动机燃烧室[A];2001年中国机械工程学会年会暨第九届全国特种加工学术年会论文集[C];2001年
6 陈改荣;杨书廷;吕庆章;郑洪河;赵林治;张明春;丁立;;Na_2SO_4-Na_2MoO_4体系的相关系IR谱分析与导电机理研究[A];第三届中国功能材料及其应用学术会议论文集[C];1998年
7 韩益苹;罗鹏;蔡称心;陆天虹;;Ir催化剂中Ir粒子平均粒径对氨氧化的电催化性能的影响[A];中国化学会第26届学术年会分析化学分会场论文集[C];2008年
8 孔庆梅;韩益苹;陆天虹;唐亚文;;炭载Ir催化剂对氨氧化的电催化性能[A];中国化学会第26届学术年会分析化学分会场论文集[C];2008年
9 张保才;蔡伟杰;徐奕德;申文杰;;Ir/CeO_2催化剂上乙醇水蒸气重整制氢反应的研究[A];第十三届全国催化学术会议论文集[C];2006年
10 南征;;消渴难治证—胰岛素抵抗(IR)浅论[A];第九次全国中医糖尿病学术大会论文汇编[C];2006年
相关重要报纸文章 前9条
1 宜众通达 杨丽丹;第一食品 追求IR和谐境界[N];上海证券报;2005年
2 记者 孙哲;近七成上市公司没有IR长期规划[N];北京商报;2013年
3 唐坤;IR顾问遭遇股改挑战[N];上海证券报;2005年
4 李月梅;全球首款IR智能现实明信片在广东肇庆首发[N];中国邮政报;2012年
5 博星投资 袁光顺;低投票率挑战股改IR成效[N];上海证券报;2005年
6 记者崔毅罗威;东风汽车:IR制度化就是我的第六感女神[N];中国经营报;2003年
7 上海润言投资咨询有限公司;股权分置改革催生IR经典战役[N];上海证券报;2005年
8 本报记者 李轩;IR公司继续扩大在华投资[N];计算机世界;2002年
9 夏丽华;避免股改后IR管理误区[N];中国证券报;2007年
相关博士学位论文 前2条
1 陈东初;Ir、W金属/金属氧化物H~+选择性电极的研究[D];华中科技大学;2004年
2 何朝政;NH_3和NO在金属Ir表面吸附与解离的第一性原理研究[D];吉林大学;2013年
相关硕士学位论文 前10条
1 唐国栋;氧化—还原中性条件下Ir(Ⅲ)和Rh(Ⅲ)催化芳烃碳氢键活化及其官能化[D];安徽理工大学;2016年
2 宋词;健脾利湿益气养阴方治疗PCOS伴IR的临床观察[D];黑龙江省中医药科学院;2016年
3 陈世龙;针刺对喂养型IR大鼠GLUT4、IRS1影响的研究[D];黑龙江中医药大学;2008年
4 陈晓宁;IR集团公司产品创新管理体系优化研究[D];西北大学;2006年
5 郁明珠;Ir催化剂对氨氧化的电催化性能的研究[D];南京师范大学;2013年
6 杨伦权;Ir纳米粒子的形貌控制及其催化性能研究[D];昆明理工大学;2012年
7 孙丽君;含有酰胺辅助配体的Ir(Ⅲ)配合物的合成及发光性质的研究[D];江南大学;2013年
8 马丽花;强可见光吸收、长寿命三重激发态Ir~Ⅲ配合物的合成及应用[D];大连理工大学;2013年
9 郑淑红;T2DM早期血管内皮舒张功能的变化及其与SF、ox-LDL、IR的相关性研究[D];第三军医大学;2010年
10 衣秀羽;强可见光吸收的Ir(Ⅲ)、Re(Ⅰ)配合物的合成与应用研究[D];大连理工大学;2013年
本文编号:1634074
本文链接:https://www.wllwen.com/zhongyixuelunwen/1634074.html